Document Detail

The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
MedLine Citation:
PMID:  11038630     Owner:  NLM     Status:  MEDLINE    
The National Marrow Donor Program has established a large and ethnically diverse registry of volunteer, unrelated stem cell donors. More than 9,000 patients world-wide have received transplants from NMDP donors. In recent years, substantial resources have been invested to increase that portion of the NMDP donor file with complete HLA-A, -B and -DR typing. While this effort has improved the likelihood of patients identifying a suitable matched unrelated donor, it has also focussed more attention on issues surrounding donor availability. Several initiatives underway or planned are intended to improve donor availability and increase the overall success of the unrelated donor stem cell transplantation.
K L Dodson; P A Coppo; D L Confer
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical transplants     Volume:  -     ISSN:  0890-9016     ISO Abbreviation:  Clin Transpl     Publication Date:  1999  
Date Detail:
Created Date:  2000-10-25     Completed Date:  2000-11-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8812419     Medline TA:  Clin Transpl     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  121-7     Citation Subset:  IM    
National Marrow Donor Program, Minneapolis, Minnesota, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Marrow Transplantation* / immunology
Continental Population Groups
Ethnic Groups
Hematopoietic Stem Cell Transplantation*
Histocompatibility Testing
Tissue Donors* / supply & distribution
Tissue and Organ Procurement / organization & administration*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after tran...
Next Document:  Searching for an unrelated haemopoietic stem cell donor--a United Kingdom perspective.